Ampicillin-sulbactam basecompared Colistin Basefor the treatment of ?acintobacter resistant to carbapenems in ventilator associated pneumonia ?

Phase 3

• Conditions: ventilator associated pneumonia ?.; Ventilator associated pneumonia; J95.851

• Registration Number: IRCT20141209020258N126
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Ages over 16 years
Ventilator-induced pneumonia with carbapenem-producing acinetobacter

Exclusion Criteria

Failure to complete the course of treatment and discontinuation of treatment (due to drug complications and death, etc.)
Dissatisfaction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
White blood cell count. Timepoint: First study, third day, seventh day and 14th day. Method of measurement: Blood test.;Erythrocyte sedimentation rate. Timepoint: First study, third day, seventh day and 14th day. Method of measurement: Blood test.;Culture of lung secretions. Timepoint: First study, third day, seventh day and 14th day. Method of measurement: Culture of lung secretions test.